Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

60.0%

6 terminated/withdrawn out of 10 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

4(50.0%)

Phase 2

2(25.0%)

N/A

2(25.0%)

8Total

Phase 1(4)

Phase 2(2)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04977830Not ApplicableWithdrawn

Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients

Role: collaborator

NCT04035629Phase 1Withdrawn

129Xe MRI in Pediatric Population With BPD

Role: lead

NCT07355231Phase 1Not Yet Recruiting

Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI

Role: lead

NCT05302817Phase 1Terminated

Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI

Role: lead

NCT05816616Withdrawn

Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation

Role: lead

NCT05433961Phase 1Terminated

Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI

Role: lead

NCT04941573Terminated

Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI

Role: lead

NCT02163681Not ApplicableCompleted

MRI for Non-Invasive Imaging in Neonates and Children

Role: collaborator

NCT01832363Phase 2Completed

Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI

Role: lead

NCT01833390Phase 2Completed

MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects

Role: lead

All 10 trials loaded